充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection Fraction
Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial
Mechanical circulatory support devices for acute right ventricular failure
The year in cardiology: heart failure: The year in cardiology 2019
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study

Editorial

2021 Jan 20;S0828-282X(21)00051-9.

JOURNAL：Can J Cardiol.

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"

JG Howlett.

4648

Keywords: angiotensin receptor/neprilysin inhibitor; HF

Full Text PDF